Format

Send to

Choose Destination
See comment in PubMed Commons below
Radiat Oncol. 2012 Oct 22;7:174. doi: 10.1186/1748-717X-7-174.

The clinical case for proton beam therapy.

Author information

1
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA. foote.robert@mayo.edu

Abstract

Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing. Proton beam therapy has the potential for improving tumor control and survival through dose escalation. It also has potential for reducing harm to normal organs through dose reduction. However, proton beam therapy is more costly than conventional x-ray therapy. This increased cost may be offset by improved function, improved quality of life, and reduced costs related to treating the late effects of therapy. Clinical research opportunities are abundant to determine which patients will gain the most benefit from proton beam therapy. We review the clinical case for proton beam therapy.

SUMMARY SENTENCE:

Proton beam therapy is a technically advanced and promising form of radiation therapy.

PMID:
23083010
PMCID:
PMC3549771
DOI:
10.1186/1748-717X-7-174
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center